CN108498594A - 一种治疗脑出血造成的运动神经受损和肌力减退的中草药组合物 - Google Patents
一种治疗脑出血造成的运动神经受损和肌力减退的中草药组合物 Download PDFInfo
- Publication number
- CN108498594A CN108498594A CN201810600771.2A CN201810600771A CN108498594A CN 108498594 A CN108498594 A CN 108498594A CN 201810600771 A CN201810600771 A CN 201810600771A CN 108498594 A CN108498594 A CN 108498594A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- cerebral hemorrhage
- muscular strength
- impaired
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010008111 Cerebral haemorrhage Diseases 0.000 title claims abstract description 38
- 230000003387 muscular Effects 0.000 title claims abstract description 37
- 210000005036 nerve Anatomy 0.000 title claims abstract description 25
- 230000007423 decrease Effects 0.000 title claims abstract description 20
- 230000001771 impaired effect Effects 0.000 title claims abstract description 17
- 239000002131 composite material Substances 0.000 title claims abstract description 8
- 241000521581 Millettia Species 0.000 claims abstract description 26
- 241000427159 Achyranthes Species 0.000 claims abstract description 23
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 23
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 23
- 241000601164 Clematis orientalis Species 0.000 claims abstract description 23
- 239000000126 substance Substances 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims description 34
- 235000004347 Perilla Nutrition 0.000 claims description 21
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 21
- 239000009636 Huang Qi Substances 0.000 claims description 17
- 235000003365 Ilex pubescens Nutrition 0.000 claims description 13
- 241001100932 Ilex pubescens Species 0.000 claims description 13
- 241000534017 Saururus chinensis Species 0.000 claims description 11
- 241000411851 herbal medicine Species 0.000 claims description 11
- 244000025670 Eleusine indica Species 0.000 claims description 10
- 235000014716 Eleusine indica Nutrition 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 7
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 2
- 208000032843 Hemorrhage Diseases 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 210000003205 muscle Anatomy 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 230000004087 circulation Effects 0.000 description 10
- 206010019468 Hemiplegia Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 8
- 210000002683 foot Anatomy 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 241000721047 Danaus plexippus Species 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 210000000133 brain stem Anatomy 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 206010018833 Haematocoele Diseases 0.000 description 4
- 208000005873 Hematocele Diseases 0.000 description 4
- 208000028389 Nerve injury Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000000593 degrading effect Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000008764 nerve damage Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 210000004227 basal ganglia Anatomy 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000001638 cerebellum Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000001699 lower leg Anatomy 0.000 description 3
- 238000004080 punching Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 208000007542 Paresis Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010052346 Brain contusion Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001127579 Flemingia philippinensis Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004552 Lacunar Stroke Diseases 0.000 description 1
- 206010051078 Lacunar infarction Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010040026 Sensory disturbance Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 206010058939 Thalamus haemorrhage Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 108010074506 Transfer Factor Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010070627 Tumour rupture Diseases 0.000 description 1
- 208000009443 Vascular Malformations Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000003096 cerebellopontine angle Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 210000004289 cerebral ventricle Anatomy 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004055 fourth ventricle Anatomy 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,其包括以下质量份的原料药:牛大力8~90份、千斤拔10~50份、牛膝10~50份、桂枝8~30份、威灵仙8~30份。本发明能修复脑出血过程中受损的运动神经,恢复肌力,有效率为96.2%,治愈率为84.9%,治疗效果显著。
Description
技术领域
本发明涉及一种中药组合物,尤其涉及一种治疗脑出血后遗症造成的运动神经受损和肌力减退的中草药组合物。
背景技术
脑出血属于一种心脑血管疾病,早期死亡率高且极易导致一系列后遗症。偏瘫和全瘫是脑出血后遗症中最常见的症状,为大脑半球皮层运动神经受损所致,具体表现为肢体肌力减退,活动不利,甚至表现完全不能活动,常伴有同侧肢体的感觉障碍。
目前,西医的治疗方法是静脉滴注脑活素、转移因子、甲强龙、丙种球蛋白等营养神经的化学药物进行治疗。而经过西医静脉给药挽救生命后,大多数患者仍然会出现脑出血造成的运动神经损伤、肌力减退的后遗症,症状表现为肢体乏力,甚至不能活动,生活无法自理。
发明内容
本发明的目的之一在于提供一种治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,该中草药组合物可有效地修复受损运动神经,恢复肌力。
本发明上述目的通过以下技术方案来实现:一种治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,包括以下质量份的原料药:牛大力8~90份、千斤拔10~50份、牛膝10~50份、桂枝8~30份、威灵仙8~30份。
本发明中,牛大力,别名猪脚笠、金钟根、山莲藕、倒吊金钟、大力薯,为豆科崖豆藤属植物美丽崖豆藤Millettia specisoa Champ.,以根入药。性味甘平,归肺、肾经,具有强筋活络之功。千斤拔(学名:Flemingia philippinensis Merr.et Rolfe),别称:蔓千斤拔(中国主要植物图说·豆科),吊马桩,吊马墩,一条根,老鼠尾,钻地风(四川)等,性味甘涩平,归肺、肾经,具有祛风除湿、舒筋活络、强筋壮骨、消炎止痛等功效。牛大力和千斤拔具有舒筋活络和强筋壮骨之功,为方中君药,用于疏通经络,促进气血运行,使受损运动神经和肌肉得到滋养修复,能强壮腰膝、强壮筋骨,恢复肌力。牛膝性味苦甘酸平,归肝、肾经,具有补肝肾、强筋骨的功效,威灵仙具有祛风湿、通经络的功效,两者为方中臣药,增强肌肉力量。桂枝性味辛、甘、温,入肺、心、膀胱经,具有运脾化湿、温通经脉和助阳化气的功效,其温通四肢经络避免寒凝血滞,促进气血运行,在方中为佐药,促进君臣药之功效。以上具强筋活络、强筋壮骨药和温通经脉药相互配合,推动气阻经络畅通,恢复及增强患者肌力。
进一步地,本发明优选为牛大力10~60份、千斤拔10~30份、牛膝15~35份、桂枝10~25份、威灵仙10~25份。
进一步地,本发明还包括以下质量份的原料药:紫苏叶8~20份、狗脊10~50份、黄芪10~20份。
紫苏叶性味辛,微温,归脾经、肺经,散寒解表,理气和中。狗脊味苦、甘,性温,归肝、肾经,祛风湿,补肝肾,强腰膝,用于风湿痹痛,腰膝酸软,下肢无力。黄芪性味甘,微温,归肺、脾、肝、肾经,补气健脾、益气升阳。在本发明中,紫苏叶、狗脊和黄芪为臣药,其中狗脊增强君药补肝肾和强壮腰膝之功,并同时能够祛风湿。紫苏叶理气和中,黄芪补气健脾,两者配合可健脾行气,有助于改善气血运行,增强君药及其他臣药之功效。
优选地:紫苏叶10~15份、狗脊10~40份、黄芪15~18份。
进一步地,本发明还包括以下质量份的原料药:桑枝15~35份、毛冬青15~30份、当归10~20份。
桑枝祛风湿,通经络,利关节,行水气,主治风湿痹痛,中风半身不遂,水肿脚气,肌体风痒,用于肩臂、关节酸痛麻木。在本方中有助通经络,增强君药之功效。毛冬青味微苦甘,性平,清热解毒,活血通脉。当归甘、辛、温,具有补血和血,调经止痛,肌肤麻木,跌扑损伤,在方中起活血化瘀作用。以上三味为方的中佐药,三者配合活血通脉,驱风通络,行气利水,增强和推动气血运行,以上君臣佐制备的组方,具有行气通络、驱风通络、复通经络、活血通络、温通经络之功,使脑出血病造成肌肉神经受损后遗症得到及时修复。
优选地:桑枝20~25份、毛冬青20~28份、当归13~18份。
进一步地,本发明还包括以下质量份的原料药:三白草10~30份、羌活8~30份、牛筋草10~50份。
三白草,又名鸡迟枫,塘边藕,性味甘,辛,寒,归经:归肺、膀胱经,主治清热解毒,凉血利水,能祛除脑内实热头痛之风,兼制脑出血患者头痛之证。羌活性温,祛寒湿,用于外感风寒、头痛无汗、寒湿痹痛、有驱风除湿之功。牛筋草性味甘,淡,平,祛风利湿,清热解毒,散瘀止血,以上三种中草药为方中使药。方中三白草、羌活、牛筋草具有驱除脑内实热,行气利水、清热解毒和促进肌体经络复通的功能,通过与君臣佐药加入运用,能提高及增强脑内出血出现运动神经损伤造成肌力、运动神经减退取得及时修复。临床疗效证明:本发明不仅具有显著修复和提升肌力、运动神经,而且提高了患者康复生活质量和不会复发的远期疗效。
优选地:三白草12~25份、羌活10~25份、牛筋草20~45份。
本发明还可通过以下方案来实现:牛大力8~90份、千斤拔10~50份、牛膝10~50份、桂枝8~30份、威灵仙8~30份、桑枝15~35份、紫苏叶10~15份。
本发明可以制成汤剂、粉剂、颗粒剂、片剂、胶囊剂及注射剂等。
本发明具有以下优点:
1.本发明人以强筋壮骨的牛大力、千斤拔、牛膝和威灵仙与温通经络的桂枝组合构成的基本方,能推动经络畅通,使受损运动神经和肌肉得到滋养修复,促进和增强肌力,逐步使受损的运动神经修复,对运动神经受损引起的肌力减退效果显著。本发明在上述基本方的基础上配伍强筋壮骨的狗脊、理气和中的紫苏叶和补气健脾的黄芪,进一步增强舒经活络、强筋健骨、祛风湿之功。更进一步地,本发明配伍桑枝当归以及毛冬青,一方面增强活血通脉、驱风通络之功,另一方面使组合兼具行气利水、凉血活血及清热解毒之功效,治疗中风、脑出血患者的兼证。本发明还配伍三白草、羌活和牛筋草,进一步增强行气利水、凉血活血及清热解毒之功效。
经临床应用,尤其针对脑出血发病于100天内,经过西医静脉给药挽救生命后,CT检测和磁共振复查检测确定脑内无淤血并且脑血管无出血,症状表现为肢体乏力,甚至不能活动的偏瘫、全瘫患者的治疗,有效率达到96%,治愈率达到84.9%。
2.本发明的组方在药性方面无相克禁忌,剂量安全,无明显毒副作用。
具体实施方式
下面结合具体实施方式对本发明作进一步详细说明,但不构成对本发明的任何限制。
本发明提供的中药组合物可根据常规工艺制成汤剂、粉剂、颗粒剂、片剂、丸剂、胶囊剂及注射剂等。服用方法:每日3次,饭后30分钟服用,20天为一个疗程。对于不能进食流食的患者,以汤剂服之,先借助胃管将100~200毫升营养液注入胃中,30min后再注入180毫升温热的中药组合物的药液。
实施例1
牛大力20份、千斤拔15份、牛膝10份、桂枝15份、威灵仙10份。
实施例2
牛大力50份、千斤拔50份、牛膝30份、桂枝25份、威灵仙15份。
实施例3
牛大力70份、千斤拔40份、牛膝35份、桂枝30份、威灵仙30份。
实施例4
牛大力20份、千斤拔25份、牛膝13份、桂枝20份、威灵仙10份、紫苏叶10份、狗脊20份、黄芪10份。
实施例5
牛大力60份、千斤拔35份、牛膝20份、桂枝30份、威灵仙15份、紫苏叶20份、狗脊40份、黄芪20份。
实施例6
牛大力80份、千斤拔50份、牛膝40份、桂枝20份、威灵仙20份、紫苏叶15份、狗脊50份、黄芪20份。
实施例7
牛大力20份、千斤拔20份、牛膝10份、桂枝10份、威灵仙8份、紫苏叶10份、狗脊15份、黄芪10份、桑枝20份、毛冬青15份、当归12份。
实施例8
牛大力42份、千斤拔42份、牛膝25份、桂枝20份、威灵仙18份、紫苏叶15份、狗脊30份、黄芪18份、桑枝25份、毛冬青25份、当归18份。
实施例9
牛大力70份、千斤拔38份、牛膝40份、桂枝20份、威灵仙20份、紫苏叶15份、狗脊45份、黄芪13份、桑枝20份、毛冬青20份、当归10份。
实施例10
牛大力50份、千斤拔50份、牛膝28份、桂枝20份、威灵仙25份、紫苏叶20份、狗脊35份、黄芪12份、桑枝28份、毛冬青30份、当归18份、三白草15份、羌活12份、牛筋草30份。
实施例11
牛大力90份、千斤拔50份、牛膝20份、桂枝18份、威灵仙20份、紫苏叶16份、狗脊28份、黄芪20份、桑枝25份、毛冬青25份、当归15份、三白草12份、羌活10份、牛筋草50份。
实施例12
牛大力80份、千斤拔50份、牛膝50份、桂枝15份、威灵仙20份、紫苏叶20份、狗脊45份、黄芪15份、桑枝18份、毛冬青18份、当归10份、三白草24份、羌活22份、牛筋草40份。
实施例13
牛大力50份、千斤拔50份、牛膝25份、桂枝18份、桑枝35份、威灵仙20份、紫苏叶15份、狗脊45份、黄芪20份、三白草12份、毛冬青22份、当归13份、牛筋草28份、羌活8份。
实施例14
牛大力50份、千斤拔30份、牛膝15份、桂枝25份、威灵仙20份。
实施例15
牛大力60份、千斤拔50份、牛膝30份、桂枝20份、威灵仙20份、桑枝30份、紫苏叶10份。
实验例1
1.患者诊断标准:临床诊断依据1995年全国第四届脑血管会议的脑出血病分类诊断标准。由医院CT或核磁共振证实为脑出血、经打孔引流积血或手术开颅的脑出血患者,经治疗后,在颅脑内未发现有出血、积血的病灶,但患者仍然出现手脚乏力、偏瘫全瘫的后遗症状。
2.病例情况
收集133例住院10~100天的脑出血后遗症患者,症状均符合1995年全国第四届脑血管会议的脑出血病分类诊断标准。133例患者中男性97例,女性36例,年龄最大的96岁,最小的14岁,住院10~20天的20例,21~60天的75例,61~100天的38例。出院时经CT复查及核磁共振复查确认患者分别是丘脑出血、第四脑室血肿、右侧基底节区脑出血、左侧基底节区脑出血、蛛网膜下腔出血、左侧小脑半球区域出血、脑干出血、双额顶枕叶脑挫裂伤出血、左侧顶枕叶脑出血,其中未做手术的脑出血患者78例,手术打孔引流积血的35例,手术开颅的20例。通过CT及核磁共振复查证实为脑内已无出血积血病灶的后遗症患者,其中吞咽困难的2例,行走需助力的70例(男性47例,女性25例);上肢偏瘫10例,下肢偏瘫12例(男性17例,女性5例);全瘫39例(男性33例,女性6例)。
3.治疗方法
取实施例11的中草药组合物经煎煮得药液。服用方法:每日3次,一次180毫升,饭后30分钟服用,20天为一个疗程。灌服:不能进食流质食物的患者,先插胃管,用注射器吸取100~200毫升营养液,借助胃管注入胃管中,30分钟后再用注射器将180毫升药液直接注入胃管中。每天灌服三次,共灌服540毫升,每隔5小时灌服一次营养液。
4.疗效标准
治愈:双脚乏力、偏瘫和全瘫的症状消失,恢复V级肌力,生活能够自理。
显效:双脚感觉仍然乏力,生活半自理。
无效:生命体征正常,后遗症状未见好转。
5.治疗结果
133例患者病发后20-100天内服用本发明的药液,服药30~100天。经治疗133例患者中,起效128例,有效率达96.2%,其中治愈113例,治愈率84.9%,显效15例,有效率11.3%。而无效5例,无效率仅3.8%。结果表明,对于在经过西医治疗挽回生命后的疾病性脑出血、手术开颅、打孔引流及跌倒撞伤造成的脑内出血的患者即使存在肢体乏力或偏瘫、全瘫的脑出血后遗症症状,但只要脑内无淤血且无出血的情况下,服用本发明的中草药组合物均有疗效。而且病发后10~20天内服药的疗效最佳。患者服药5~10天后肌力减退的情况好转,服药10~30天后,偏瘫、全瘫的重度患者大小腿肌力逐渐恢复,四肢乏力的轻度患者完全治愈,走路无需助力。以下为部分临床治疗结果:
1.患者信息:
赖某,男,63岁,2014年6月10日至2014年7月10日在广东省梅州市黄塘医院接受治疗。诊断:脑干出血,基底节腔隙性脑梗塞,高血压3级。运用西医疗法静脉给药,住院30后出院,出院时CT复查显示,脑干出血半暗区消失,出血部位未见血肿及积液,病灶周围无水肿。后遗症状:左脚运动肌力障碍,运动失调,行走需人扶助;右手乏力,进食需要帮助;自说头部左侧及面部麻痹。出院后口服西药一个月,未见症状好转。2017年8月12日患者右脚跨步乏力,失去着力功能,右手乏力,不能拖物,左侧面部麻痹,生活不能自理,病残程度10级。经CT头部扫描证实为脑干出血与左脑梗塞合并症,其症状符合1995年全国第四届脑血管会议的脑出血病分类诊断标准。结合CT复查结果和临床中医辩证分析,判断患者的情况属于右腿经络损伤造成的肌力功能减退。
治疗方法
2014年8月14日停止口服西药,开始服用本发明实施例1的中药组合物经煎煮得药液。每日3次,饭后30分钟口服中药组合物的药液,一次180毫升,20天为一疗程。
治疗结果
口服本发明10日后,患者右脚肌力提升,可缓慢行走而无需别人扶助,但不能做蹲站动作。口服本发明60日后,患者肌力恢复正常,生活完全自理。
2.患者信息:
李某,女,14岁,2017年7月23日突发左手和右脚无力,流涎,被送往广东省梅州市黄塘医院接受治疗。CT检测结果显示,左侧桥小脑角区-脑桥左侧部-桥臂-左侧小脑半暗区域血肿7.5mL,疑为血管畸形或肿瘤破裂出血,蛛网膜下腔出血。住院期间西医静脉滴药,营养神经,缓解血管痉挛。10日后CT复查显示,左侧桥小脑、左侧小脑半暗区域高密度影消失,脑室系统形态、大小及密度正常,血肿消失,但患者仍然四肢乏力,腰肌坐力失调,医师诊断为脑出血后遗症。8月3日患者遗憾出院时,患者神志疲倦,颈椎无法直立,流涎,双脚乏力,需人扶助移步行走,右手不能拿物,生活不能自理,病残程度6级。患者经CT头部扫描证实为脑干出血,其症状符合1995年全国第四届脑血管会议的脑出血病分类诊断标准。患者出院时CT复查显示,血肿消失,但出现脑出血后遗症,出现肌力、神经受损,双脚着力功能失调,右手及颈椎肌力减退,运动神经损伤。
治疗方法
2017年8月3日,患者开始服用本发明实施例13的中药组合物经煎煮得药液。每日3次,饭后30分钟口服中草药药液,一次180毫升,20天为一疗程。用药期间,每日下午2时用42~45℃温水冲凉,同时按摩肌力减退部位。
治疗结果
口服本发明10日后,患者双脚肌力提升,独自跨步慢行,双脚着力平稳,颈椎肌力恢复。口服本发明20日后,患者肌力恢复正常,生活自理。
Claims (9)
1.一种治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,其特征在于,包括以下质量份的原料药:
牛大力8~90份、千斤拔10~50份、牛膝10~50份、桂枝8~30份、威灵仙8~30份。
2.根据权利要求1所述的治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,其特征在于,所述中药组合物包括以下质量份的原料药:
牛大力10~60份、千斤拔10~30份、牛膝15~35份、桂枝10~25份、威灵仙10~25份。
3.根据权利要求1或2所述的治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,其特征在于,还包括以下质量份的原料药:
紫苏叶8~20份、狗脊10~50份、黄芪10~20份。
4.根据权利要求3所述的治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,其特征在于,紫苏叶10~15份、狗脊10~40份、黄芪15~18份。
5.根据权利要求3或4所述的治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,其特征在于,还包括以下质量份的原料药:
桑枝15~35份、毛冬青15~30份、当归10~20份。
6.根据权利要求5所述的治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,其特征在于,桑枝20~25份、毛冬青20~28份、当归13~18份。
7.根据权利要求5或6所述的治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,其特征在于,还包括以下质量份的原料药:
三白草10~30份、羌活8~30份、牛筋草10~50份。
8.根据权利要求7所述的治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,其特征在于,三白草12~25份、羌活10~25份、牛筋草20~45份。
9.根据权利要求1所述的治疗脑出血造成的运动神经受损和肌力减退的中草药组合物,其特征在于,包括以下质量份的原料药:
桑枝15~30份、紫苏叶10~15份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810600771.2A CN108498594A (zh) | 2018-06-12 | 2018-06-12 | 一种治疗脑出血造成的运动神经受损和肌力减退的中草药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810600771.2A CN108498594A (zh) | 2018-06-12 | 2018-06-12 | 一种治疗脑出血造成的运动神经受损和肌力减退的中草药组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108498594A true CN108498594A (zh) | 2018-09-07 |
Family
ID=63403304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810600771.2A Pending CN108498594A (zh) | 2018-06-12 | 2018-06-12 | 一种治疗脑出血造成的运动神经受损和肌力减退的中草药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108498594A (zh) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107261026A (zh) * | 2017-07-31 | 2017-10-20 | 王辉 | 一种防治风湿筋骨痛的药酒及其制备方法 |
-
2018
- 2018-06-12 CN CN201810600771.2A patent/CN108498594A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107261026A (zh) * | 2017-07-31 | 2017-10-20 | 王辉 | 一种防治风湿筋骨痛的药酒及其制备方法 |
Non-Patent Citations (5)
| Title |
|---|
| 刘晓松等: "益气通脑方对脑卒中后下肢运动功能恢复的影响", 《中国实验方剂学杂志》 * |
| 叶华谷等: "《中国药用植物.十一》", 31 October 2016, 化学工业出版社 * |
| 广西壮族自治区医药公司: "《广西壮族自治区南宁市中草药展览交易会资料选编》", 28 February 1975, 广西壮族自治区医药公司 * |
| 赵秀贞: "《常用青草药彩色图集》", 31 October 2015, 海峡出版发行集团 福建科学技术出版社 * |
| 赵英强: "《孙兰军临证经验实录》", 31 July 2015, 人民军医出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100402066C (zh) | 一种治疗风湿、骨关节疾病的膏药 | |
| CN101391077B (zh) | 一种治疗慢性盆腔炎的中药制备方法 | |
| CN103463349B (zh) | 一种治疗急性腰扭伤的中药组合物 | |
| CN103356877A (zh) | 一种治疗骨科疾病的中药组合物 | |
| CN102274385B (zh) | 一种治疗鼻窦炎的药物及其制备方法 | |
| CN103356953B (zh) | 一种治疗腰肌劳损的中药组合物 | |
| CN106039245A (zh) | 一种治疗风湿骨病的外用中药矿泉泥及其制备方法 | |
| CN101129973A (zh) | 一种治疗颈椎病的中药 | |
| CN101721651B (zh) | 一种治疗肩周炎的中药胶囊 | |
| CN104587225A (zh) | 一种治疗颈椎病的中药组合物 | |
| CN104645078A (zh) | 一种治疗偏头痛的中药组合物 | |
| CN104162088A (zh) | 一种舒筋活络祛湿的中药组合物及其制备方法 | |
| CN104606561A (zh) | 一种治疗自汗的中药组合物 | |
| CN104523999B (zh) | 一种用于骨质疏松的中药制剂及其膏剂的制备方法 | |
| CN103251754A (zh) | 一种治疗褥疮的中药组合物 | |
| CN108186749A (zh) | 治疗颈椎病的中药组合物及其制备方法 | |
| CN108498594A (zh) | 一种治疗脑出血造成的运动神经受损和肌力减退的中草药组合物 | |
| CN106540229A (zh) | 一种治疗寒性痛病的外用药酒及其制备方法 | |
| CN104784417A (zh) | 一种治疗阳萎的中药组合物 | |
| CN104173932A (zh) | 一种治疗颈椎病的中药组合物 | |
| CN102824546B (zh) | 一种治疗肾阴亏虚型闭合性骨折的中药洗剂制备方法 | |
| CN109865010A (zh) | 治疗风湿性关节炎、骨质增生和腰椎间盘突出的药酒及其制备方法 | |
| CN101897764A (zh) | 治疗坐骨神经痛的中药制剂 | |
| CN105194411A (zh) | 一种治疗肩周炎的中药配方 | |
| CN104758851A (zh) | 一种治疗中风后遗症的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180907 |